Danielle Boyle: Patient Voices Transform Progress in ITP Research and Care with ISTH
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, shared International Society on Thrombosis and Haemostasis (ISTH)’s post on LinkedIn, adding:
“I’m incredibly grateful to ISTH for sharing this member spotlight and for recognising the importance of patient voices in ITP research and care.
Founding ITP Australia and New Zealand has shown me, time and time again, that meaningful progress happens when patients, clinicians and researchers work together.
Lived experience brings context, clarity and humanity to the data, and it’s often the missing piece that helps shape research questions, treatment priorities and real ‑ world outcomes.
Hearing the stories, challenges and insights from people living with ITP is what drives this work forward.
Their voices don’t just inform research; they transform it.
Thank you to the International Society on Thrombosis and Haemostasis (ISTH) for highlighting the value of patient ‑ led organisations and for continuing to champion collaboration across the global haematology community.
I’m proud to be a member and part of a network that understands the power of partnership and the impact of listening deeply to the people at the heart of this condition.
- Grateful for the recognition.
- Grateful for the community.
- Grateful for the opportunity to keep pushing for better outcomes.”
International Society on Thrombosis and Haemostasis (ISTH) , shared a post on LinkedIn:
“Meet ISTH member Danielle Boyle, founder and CEO of ITP Australia and New Zealand.
In this video, she highlights the powerful role patient voices play in shaping meaningful research and improving outcomes for the ITP community.
We’re always so inspired to hear about the amazing work that our members are doing across the globe! ”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 15:03Wolfgang Miesbach: The Most Underappreciated Challenges in Haemophilia Care Tackled at WFH 2026
-
Apr 20, 2026, 14:48Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
-
Apr 20, 2026, 14:46Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation
-
Apr 20, 2026, 14:45New Leadership and Expanding Global Impact in Hemophilia – WFH
-
Apr 20, 2026, 14:43Michael Baffuor-Asare: Rethinking How We Manage Rare Blood Groups
-
Apr 20, 2026, 14:42Noor Ahmed Mirwani: Infectious Mononucleosis Through the Lens of Atypical Lymphocytes
-
Apr 20, 2026, 14:40Irma Rastegayeva: The Evolution of Healthcare Access – From Royal Free Hospital to the Modern NHS
-
Apr 20, 2026, 14:37Brian O Mahony: With Old Friends From The Vietnam Haemophilia Association at WFH Congress 2026
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis